We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Most Gymnema Sylvestre studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from high-quality meta-analyses and randomised trials published 2007–2025.
Based on 12 studies · 2 meta-analyses · 5 RCTs
Confidence
High
By outcome
Glucose & metabolicModest reductions in fasting blood glucose and HbA1c, mainly in type 2 diabetes · 8-12 weeks · Improvements in glucose and lipid markers in metabolic syndrome · 8-12 weeks
Mostly mechanism / observational6 studies
Weight managementReduced sweet cravings and sugar intake may support weight management · 2-12 weeks
Too few graded studies2 studies
Lean body mass & muscle growth
Too few graded studies1 study
Heart & blood pressure
Too few graded studies1 study
Cholesterol & lipids
Too few graded studies1 study
Active research area
6 studies in the last 5 years · Latest meta-analysis: 2023
200720162025
1Meta-Analysis2021
Pooled RCTs showed Gymnema sylvestre supplementation improved glycemic control in type 2 diabetes.
Devangan S et al. · Phytotherapy research : PTR (2021)
Significant reductions in fasting blood glucose and HbA1c versus control